Loading company…
Oryon Cell Therapies develops cell therapies for medical conditions, including Parkinson’s disease.
Founded in 2020 and based in Belmont, US, Oryon Cell Therapies develops regenerative medicine treatments. In March 2026, it raised USD 21.00 mn in Series A funding from Byers Capital and Neuro.VC to support clinical studies and research on neuron replacement therapies for Parkinson’s disease.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in